SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Seo Jung-jin
Rank #340 · Healthcare

Seo Jung-jin

Biotech · South Korea

Net worth$10.0B
Today−$100M
7 days+$35
30 days+$899M

Net worth, last 30 days

Low $8.8BHigh $10.1B

Biography

Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others.

With the success of biosimilars in South Korea, his Celltrion has become a favorite among investors.

In 2023, Seo returned as chairman of his Celltrion group, two years after stepping down from the role, and pledged to make major acquisitions.

Seo's eldest son Jin-seok is cochairman of Celltrion Inc.

Seo started Celltrion Inc. in 2002 and took it public in 2008.

Did you know

Seo is a former employee of Samsung Electro-Mechanics.

Holdings

CompanyTickerSharesValue
Celltrion Inc.068270-KR66,259,200$14.25T
Private assets & other$565M

Public holdings ≈ $14.25T. Holdings may include options and overlap between rows.